Institutional investors purchased a net $36.3 million shares of AZN during the quarter ended March 2016 and now own 10.21% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 105.6 Thousand shares of AstraZeneca
CIBC WORLD MARKETS, INC. Bought 35.2 Thousand shares of AstraZeneca
NEUBERGER BERMAN LLC Bought 35.1 Thousand shares of AstraZeneca